May 18 - 20, 2023 Goias - Brazil

Schedules – 19th

Event hibrid Information of Event Schedules

Registration: Paid according to category. Some workshops are free
Place: Pousada dos Pireneus at Pinenópolis in Goiás / Brazil
Audience: breast cancer specialist, oncology surgeons, clinical oncologists, pathologists, epidemiologists, radiotherapists, radio-oncologists, 

 physiotherapists and everyone in the health care area who deals with breast cancer.
Climate: Hot during the day and cold at night. It may rain during the day.
Shoe: advisable for women to wear chunky or block heels.

8:25AM FROM 6:00PM

SIMULTANEOUS ROOM

HYBRID + WITH TRANSLATION

8:25AM FROM 8:55AM

Commented poster session 1

Coordinator:
FRANCINE FISCHER SGROTT (BRA)

Discussants:
ANDRÉ MATTAR (BRA)
MARCUS NASCIMENTO BORGES (BRA)

8:25AM FROM 8:28AM

Rosangela da Silveira Corrêa (BRA)

Adherence of community health agents (ACS) to a breast cancer screening program – Itaberaí Project

ROSANGELA DA SILVEIRA CORRÊA (BRA)

8:28AM FROM 8:31AM

Leonardo Ribeiro Soares (BRA)

Kinesiotherapy and quality of life after breast cancer surgery: a systematic review with meta-analysis

LEONARDO RIBEIRO SOARES (BRA)

8:31AM FROM 8:34AM

ANDRESSA AMORIM (BRA)

Accuracy of stereotactic vaccum-assisted breast biopsy for investigating suspicious calcifications in 2,021 patients a public hospital in Brazil

ANDRESSA AMORIM (BRA)

8:34AM FROM 8:37AM

René Aloisio da Costa Vieira (BRA)

Periodontal disease as a risk factor for breast cancer: a case-control study based on a comprehensive clinical periodontal evaluation

RENÉ ALOISIO DA COSTA VIEIRA (BRA)

8:37AM FROM 8:40AM

Aline Ferreira Bandeira de Melo Rocha (BRA)

Screening and diagnosis of breast cancer in older women in Brazil: why should recommendations be reconsidered?

ALINE FERREIRA BANDEIRA DE MELO ROCHA (BRA)

8:40AM FROM 8:43AM

Martina Lichtenfels (BRA

Breast cancer biomarkers of resistance to neoadjuvant chemotherapy

MARTINA LICHTENFELS (BRA)

8:43AM FROM 8:55AM

Discussion

8:55AM FROM 9:30AM

Mini conference: HER-2 low: a new perspective towards an old acquainted

Chairman:
VICTOR DOMINGOS LISITA ROSA (BRA)

Speaker:
LEANDRO GONÇALVES OLIVEIRA (BRA)

9:20AM FROM 9:30AM

Discussion

9:30AM FROM 10:05AM

Mini conference: Which information can the Venus Trial add to the Sound Trial in terms of axillary approach?

Chairwoman:
EVELLING LORENA CERQUEIRA DE OLIVEIRA (BRA)

Speaker:
GIULIANO MENDES DUARTE (BRA)

9:55AM FROM 10:05AM

Discussion

10:05AM FROM 10:30AM

Coffee Break

10:30AM FROM 11:00AM

Commented poster session 2

Coordinator:
MARTINA LICHTENFELS (BRA)

Discussants:
CARLOS ALEXANDRE VIEIRA (BRA)
JOSÉ LUIZ PEDRINI (BRA)

10:30AM FROM 10:33AM

Marcelo Antonini (BRA)

Real world evidence of predictors of pathologic complete response and impact on overall survival in breast cancer patients treated with neoadjuvant chemotherapy

MARCELO ANTONINI (BRA)

10:33AM FROM 10:36AM

Luana Cristina Camargo (BRA)

Immunotherapy vaccines for triple-negative breast cancer and its influence in the tumor microenvironment

LUANA CRISTINA CAMARGO (BRA)

10:36AM FROM 10:39AM

René Aloisio da Costa Vieira (BRA)

Evaluation of upper limb lympedema using spectroscopic bioimpedance in a brazilian population

RENÉ ALOISIO DA COSTA VIEIRA (BRA)

10:39AM FROM 10:42AM

Victor Domingos Lisita Rosa (BRA)

Impact of the COVID-19 pandemic on cancer care in 2020 and 2021 in a Brazilian healthcare center

VICTOR DOMINGOS LISITA ROSA (BRA)

10:42AM FROM 10:45AM

ISABELLA BARROS RABELO GONTIJO TUMEH (BRA)

Comfort Program: accessible strategy to give voice to a little heard patient

ISABELLA BARROS RABELO GONTIJO TUMEH (BRA)

10:45AM FROM 10:48AM

ANDRÉ MATTAR (BRA)

Clinical and pathological differences between HER2 Low and other cancer subtypes in breast cancer patients.

ANDRÉ MATTAR (BRA)

10:48AM FROM 11:00AM

Discussion

11:05AM FROM 11:30AM

Mini conference: Encephalitis for neoplasms associated with breast cancer

Chairwoman:
MARA COSTA DUTRA (BRA)
Speaker:
RAFAEL BASTISTA JOÃO (BRA)

11:30AM FROM 11:40AM

Discussion

11:45AM FROM 12:10PM

Mini conference: Reducing the side effects of systemic therapy with physical exercises. What and when?

Chairman:
RODRIGO PEPE (BRA)
Speaker:

CARLOS ALEXANDRE VIEIRA (BRA)

12:10PM FROM 12:20PM

Discussion

2:00PM FROM 2:30PM
2:00PM FROM 2:03PM

Marcelo Antonini (BRA)

How long does it take to start breast cancer treatment in Brazil? Is the 60 Day Law fulfilled?

MARCELO ANTONINI (BRA)

2:03PM FROM 2:06PM

Arethuzza Alves Moreira (BRA)

Predictors of biopsychosocial distress in women with locally advancedand/or metastatic breast cancer

ARETHUZZA ALVES MOREIRA (BRA)

2:06PM FROM 2:09PM

Flávio Lúcio Vasconcelos (BRA)

Tumor profile and treatment used in elderly women with breast cancer in a tertiary referral hospital

FLÁVIO LÚCIO VASCONCELOS (BRA)

2:09PM FROM 2:12PM

Gustavo Moreira Andrade (BRA)

The use of epigenetics in the treatment of triple negative breast cancer, focusing on IncRNA

GUSTAVO MOREIRA ANDRADE (BRA)

2:12PM FROM 2:15PM

Fabiana Christina Araújo Pereira Lisboa (BRA)

Better aesthetic results after oncoplastic surgery than after total breast reconstruction according to patients and surgeons

FABIANA CHRISTINA ARAÚJO PEREIRA LISBOA (BRA)

2:15PM FROM 2:18PM

René Aloisio da Costa Vieira (BRA)

Extreme oncoplasty: past, present and future

RENÉ ALOISIO DA COSTA VIEIRA (BRA)

2:18PM FROM 2:30PM

Discussion

2:35PM FROM 3:50PM

Table: Breast cancer locoregional treatment  in 2023

Chairman:
GUILHERME NOVITA GARCIA (BRA)
Speakers:
20’ To which extent can I de-escalate the axillary surgery?

RENATO CAGNACI NETO (BRA)
20’ How to combine aesthetics and safety in the locoregional treatment?
CÍCERO DE ANDRADE URBAN (BRA)
20’ Partial breast irradiation, hypofractionated irradiation and new technologies
MARCUS SIMÕES CASTILHO (BRA)

3:35PM FROM 3:50PM

Discussion

3:50PM FROM 4:30PM

Coffee Break

4:30PM FROM 5:00PM
4:30PM FROM 4:33PM

Ana Filipa Ferreira Goulart (BRA)

Bilobed LICAP for breast conservation – technique description and ten-year retrospective

ANA FILIPA FERREIRA GOULART (BRA)

4:33PM FROM 4:36PM

Laíse Alves Ribeiro (BRA)

Screening for ocular tamoxifen toxicity versus neurological metastasis in breast cancer: a systematic review

LAÍSE ALVES RIBEIRO (BRA)

4:36PM FROM 4:39PM

Daniel Buttros (BRA)

Negative impact of adjuvant endocrine therapy on sexual function in breast cancer survivors

DANIEL BUTTROS (BRA)

4:39PM FROM 4:42PM

Lara Cristina Ferraz (BRA)

Serum hemoglobin and relation to the staging of patients with breast cancer before the start of radical radiotherapy

LARA CRISTINA FERRAZ (BRA)

4:42PM FROM 4:45PM

Aline Ferreira Bandeira de Melo Rocha (BRA)

Covid-19 and breast cancer in elderly women in Brazil

ALINE FERREIRA BANDEIRA DE MELO ROCHA (BRA)

4:45PM FROM 4:48PM

Priscila Dias Watanabe (BRA)

Influence of surgical clip and oncoplasty on breast, heart and lung volumes irradiated during boost radiotherapy in breast cancer

PRISCILA DIAS WATANEBE (BRA)

4:48PM FROM 5:00PM

Discussion

5:05PM FROM 5:40PM

Mini conference: Fluorostradiol (FES) PET-CT: which patients may benefit and why

Chairman:
RAFAEL GONÇALVES PORTELA (BRA)
Speaker:
WHEMBERTON MARTINS DE ARAÚJO (BRA)

5:30PM FROM 5:40PM

Discussion

8:25AM - 8:35AM

Isabela Panzeri Carlotti Buzatto (BRA)

Machine learning can reliably predict malignancy of BI-RADS; 4a and 4b breast lesions based on clinical and ultrasonographic features

ISABELA PANZERI CARLOTTI BUZATTO (BRA)

8:35AM - 8:45AM

Tahmina kosayeva (AZE)

Management of locoregional lymph node metastasis from occult breast cancer

TAHMINA KOSAYEVA (AZE)

8:45AM - 8:55AM

Douglas Euclides da Silva (BRA)

Pink App: strategy for resolving breast cancer screening actions according to the Itaberaí Project

DOUGLAS EUCLIDES DA SILVA (BRA)

8:55AM - 9:10AM

Discussion

9:15AM - 9:45AM

Gold Satellite Symposium - Novartis: Updates on cyclin inhibitors in the treatment of HR+/HER2- metastatic cancer

Chairwoman:
ROSEMAR MACEDO SOUSA RAHAL (BRA)

Speaker:
ANDERSON ARANTES SILVESTRINI (BRA)

9:45AM - 10:10AM

Mini conference: Management of hereditary moderate-risk genes for breast cancer

Chairwoman:
DEIDIMAR CASSIA BATISTA ABREU (BRA)
Speaker:

MARIA ISABEL WADDINGTON ACHATZ (BRA)

10:05AM - 10:10AM

Discussion

10:10AM - 10:40AM

Coffee Break

10:40AM - 10:50AM

ANDRESSA AMORIM (BRA)

Vaccun assisted biopsy for breast carcinoma diagnosis: cost-minimization analysis

ANDRESSA AMORIM (BRA)

10:50AM - 11:00AM

HENRIQUE LIMA COUTO (BRA)

Digital breast tomosynthesis added to synthetic mammography (DBT + s2D) in women with partially fatty or heterogeneously dense breasts (patterns 2 and 3 ACR BI-RADS): systematic review, meta-analysis and clinical outcomes in brazilian breast cancer screening

HENRIQUE LIMA COUTO (BRA)

11:00AM - 11:10AM

Danielle Cristina Netto Rodrigues (BRA)

Preliminary results of breast cancer screening based on physical breast examination by community health agent (ACS) – Projeto Itaberaí

DANIELLE CRISTINA NETTO RODRIGUES (BRA)

11:10AM - 11:25AM

Discussion

11:30AM -11:50AM

Daniele Assad Suzuki (BRA)

Silver Satellite Symposium - Lilly: From early stages to metastatic cancer: updates on abemaciclib in the treatment of HR+ HER2- breast cancer

DANIELE ASSAD SUZUKI (BRA)

11:55AM -12:05PM
12:05PM -12:25PM

Mini conference: Antineoplastic agents in breast cancer and access to supplementary health

Chairwoman:
Speaker:

12:25PM -12:30PM

Discusssion

12:30PM -1:45PM

Lunch with experts - Roche

Local: CENTRO DE CONVENÇÕES DO CARMO

Speakers:
DANIELE ASSAD SUZUKI (BRA)
KARIMI AMARAL (BRA)

2:00PM - 2:10PM

Danielle Cristina Miyamoto Araújo (BRA)

Sentinel lymph node biopsy VErsus No axillary surgery in early breast cancer clinically and UltraSonographically node negative: a prospective randomized controlled trial – VENUS trial early results after 3.5 years of study inception

DANIELLE CRISTINA MIYAMOTO ARAÚJO (BRA)

2:10PM - 2:20PM

Vinícius Milani Budel

Oncological outcomes of selective axillary dissection using carbon as a marker

VINICIUS MILANI BUDEL (BRA)

2:20PM - 2:30PM

Martina Lichtenfels (BRA

What happens in residual disease after neoadjuvant chemotherapy? Efficacy of a novel in vitro breast cancer chemoresistance platform to demonstrate high resistance to drugs

MARTINA LICHTENFELS (BRA)

2:30PM - 2:45PM

Discussion

2:50PM - 3:30PM

Diamond Satellite Symposium – MSD: Imunoterapy in TNBC patients KN 522 updates

Chairman:
ANDRÉ MATTAR
Speaker:

HEATHER LYNN MCARTHUR (USA)

3:35PM - 4:15PM

Diamond Satellite Symposium - Daiichi Sankyo | Astrazeneca: HER2 low disease: a multidisciplinary approach

Chairman:
Speaker:

4:15PM - 4:45PM

Coffee Break

4:45PM - 5:10PM

Mini conference: Two-stage breast reconstruction

Chairman:
FRANK LANE BRAGA RODRIGUES (BRA)
Speaker:
ALOISIO GARCIA DE SOUZA (BRA)

5:05PM - 5:10PM

Discussion

5:15PM - 5:25PM

Daniel Buttros (BRA)

High risk of metabolic dysfunction in non-obese breast cancer survivors

DANIEL BUTTROS (BRA)

5:25PM - 5:35PM

Fabio Postiglione Mansani (BRA)

MammaPrint™ 70-gene signature with ultralow-risk profile - characteristics and results in the AGEMA-BRA cohort

FABIO POSTIGLIONE MANSANI (BRA)

5:35PM - 5:45PM

Danielle Laperche dos Santos (BRA)

Quality of life in Brazilian women with early breast cancer on adjuvant endocrine therapy

DANIELLE LAPERCHE DOS SANTOS (BRA)

5:45PM - 6:00PM

Discussion

8:25AM FROM 12:00PM

SBRT CONSENSUS MEETING
HYPOFRACTIONED BREAST IRRADIATION

FACE-TO-FACE

Apresentação:
MARCUS SIMÕES CASTILHO (BRA)
NILCEANA MAYA AIRES FREITAS (BRA)
ARTHUR ACCIOLY ROSA (BRA)
GUSTAVO NADER MARTA (BRA)

 

1 ST stage result for the consensus voting
NILCEANA MAYA AIRES FREITAS (BRA)

 

Methodology and presentation of issues that have not reached consensus

 

MODULE I Ideal patient for moderate hypofractioned breast irradiation
NILCEANA MAYA AIRES FREITAS (BRA)

 

MODULE II Ideal patient for ultra-hypofractioned breast irradiation
GUSTAVO NADER MARTA (BRA)

 

MODULE III Hypofractionation breast partial external RT
PEDRO HENRIQUE DA ROCHA ZANUNCIO (BRA)

 

MODULE IV Applied technology
Techniques for planning and image verification  - SAMIR ABDALLAH HANNA (BRA)

 

Constraints related to moderate hypofractioned RT and constraints related to ultra-hypofractioned RT - CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS (BRA)

 

Discussion
New voting on the issues that did not reach consensus

 

Radio-oncologist panelists:
ALLISSON BRUNO BARCELLOS BORGES (BRA)
ANDRE CAMPANA (BRA)
ARTHUR ACCIOLY ROSA (BRA)
CLAUDIA REGINA SCARAMELLO HADLICH WILLIS FERNANDEZ (BRA)
CONCEIÇÃO APARECIDA MACHADO DE SOUZA CAMPOS (BRA)
FERNANDO MARIANO OBST (BRA)
GUILHERME ROCHA MELO GONDIM (BRA)
GUSTAVO NADER MARTA (BRA)
HELOÍSA DE ANDRADE CARVALHO (BRA)
JEAN PAIVA (BRA)
MARCUS SIMÕES CASTILHO (BRA)
NILCEANA MAYA AIRES FREITAS (BRA)
PEDRO HENRIQUE DA ROCHA ZANUNCIO (BRA)
SAMIR ABDALLAH HANNA (BRA)
WILSON JOSÉ ALMEIDA JR (BRA)
LILIAN FARONI (BRA)

 

AD HOC Consultants:
Brazilian Society of Mastology (SBM):
ANDRÉ MATTAR (BRA)
RUFFO DE FREITAS JUNIOR (BRA)

 

Brazilian Society of Surgical Oncology:
RODRIGO LEITE (BRA)

 

Brazilian Society of Clinical Oncology:
CRISTIANO AUGUSTO ANDRADE DE RESENDE (BRA)

2:00PM FROM 2:10PM

RUFFO DE FREITAS JUNIOR (BRA)

Abertura da Reunião / Boas Vindas

RUFFO DE FREITAS JÚNIOR (BRA)

2:10PM FROM 2:20PM

RUFFO DE FREITAS JUNIOR (BRA)

Escolha dos Centros de Pesquisa e Responsabilidades dos
Investigadores Principais (PI)

RUFFO DE FREITAS JÚNIOR (BRA)

2:20PM FROM 2:30PM

Paulo Henrique Otoni

A importância das ações do Ministério Público do Estado na tramitação e articulação do Projeto ITABERAÍ Promotor de Justiça do Ministério Público do Estado de Goiás

PAULO HENRIQUE OTONI (BRA)

2:30PM FROM 2:40PM

Danielle Cristina Netto Rodrigues (BRA)

Apresentação do Projeto ITABERAÍ e Resultados Preliminares

DANIELLE CRISTINA NETTO RODRIGUES (BRA)

2:40PM FROM 2:50PM

Douglas Euclides da Silva (BRA)

Desenvolvimento do Aplicativo Rosa e sua relevância para o Projeto ITABERAÍ
Tecnologia da Informação da Secretaria Municipal de Saúde de Itaberaí

DOUGLAS EUCLIDES DA SILVA (BRA)

2:50PM FROM 4:15PM

Danielle Cristina Netto Rodrigues (BRA)

O engajamento das Coordenações da Rede de Atenção à Saúde para a efetividade do Projeto ITABERAÍ

Coordenção:
DANIELLE CRISTINA NETTO RODRIGUES (BRA)

2:50PM FROM 3:00PM

Christina Souto Cavalcante Costa

A experiência do profissional da Rede de Atenção à Saúde no acompanhamento dos Agentes Comunitários de Saúde para a realização do exame físico da mama.

Enfermeira navegadora/monitora do Projeto Itaberaí

CHRISTINA SOUTO CAVALCANTE COSTA (BRA) (BRA)

3:00PM FROM 3:10PM

Nicaella Eterna de Oliveira Santos Nascimento

A importância do comprometimento da Coordenação da Atenção Básica para a construção dos pilares do Projeto ITABERAÍ: treinamento e rastreamento.
Coordenadora da Rede de Atenção Básica de Itaberaí

NICAELLA ETERNA DE OLIVEIRA SANTOS NASCIMENTO (BRA)

3:10PM FROM 3:20PM

Regina Lopes da silva

Desafios e conquistas para resolutividade do fluxo de pacientes
para o diagnóstico e tratamento do câncer de mama. Diretora de Regulação da Secretaria Municipal de Saúde de
Itaberaí

REGINA LOPES DA SILVA (BRA)

3:20PM FROM 3:30PM

Maria do Carmo Egito de Sá

Exames de imagem e biópsia de mama e seu processo de descentralização.
Diretora Técnica do Hospital Municipal de Itaberaí

MARIA DO CARMO EGITO SÁ (BRA)

3:30PM FROM 3:40PM

Carlos Rodrigues Galvão Júnior

O impacto do Projeto ITABERAÍ nas ações da Secretaria Municipal de Saúde.
Secretário Municipal de Saúde de Itaberaí

CARLOS RODRIGUES GALVÃO JÚNIOR (BRA)

3:40PM FROM 3:50PM

Rita de Cássia Soares Mendonça

A importância da interação entre os poderes Executivo, Judiciário e Legislativo para o desenvolvimento do Projeto ITABERAÍ
Prefeita do Município de Itaberaí

RITA DE CÁSSIA SOARES MENDONÇA (BRA)

3:50PM FROM 4:15PM

Discussão

4:15PM FROM 4:45PM

Coffe Break

4:45PM FROM 6:00PM

Christina Souto Cavalcante Costa

Ética em Pesquisa e Estudo Multicêntrico

Coordenação:
CHRISTINA SOUTO CAVALCANTE COSTA (BRA)

4:45PM FROM 4:55PM

VIVIENNE CASTILHO (BRA)

Boas Práticas Clínicas em Pesquisa Gerente de Ciências Médicas – Libbs

VIVIENNE CARDUZ CASTILHO (BRA)

4:55PM FROM 5:05PM

VIVIENNE CASTILHO (BRA)

Processo Regulatório e Monitoramento dos Centros de Pesquisa Participantes
Gerente de Ciências Médicas – Libbs

VIVIENNE CARDUZ CASTILHO (BRA)

5:05PM FROM 5:15PM

RUFFO DE FREITAS JUNIOR (BRA)

Quais os próximos passos para a implantação do Projeto ITABERAÍ nos Centros de Pesquisa participantes e suas respectivas responsabilidades?

RUFFO DE FREITAS JÚNIOR (BRA)

5:15PM FROM 5:50PM

Discussão

5:50PM FROM 6:00PM

RUFFO DE FREITAS JUNIOR (BRA)

Encerramento

RUFFO DE FREITAS JÚNIOR (BRA)